{"slideshow_credits": null, "snippet": "The British drug giant GlaxoSmithKline said it paid about $1.05 billion to increase its stake in GlaxoSmithKline Pharmaceuticals Limited to 75 percent from 50.7 percent.", "abstract": "The British drug giant GlaxoSmithKline said it paid about $1.05 billion to increase its stake in GlaxoSmithKline Pharmaceuticals Limited to 75 percent from 50.7 percent.", "section_name": "Business Day", "print_page": null, "document_type": "blogpost", "byline": {"person": [{"firstname": "Chad", "role": "reported", "lastname": "BRAY", "rank": 1, "organization": ""}], "original": "By CHAD BRAY"}, "web_url": "http://dealbook.nytimes.com/2014/03/10/glaxosmithkline-increases-stake-in-indian-pharmaceutical-unit/", "lead_paragraph": null, "headline": {"main": "GlaxoSmithKline Increases Stake in Indian Pharmaceutical Unit", "kicker": "DealBook"}, "_id": "531d922838f0d85d201f784b", "word_count": "183", "multimedia": [{"height": 126, "url": "images/2014/03/10/business/dbpix-glaxo2/dbpix-glaxo2-thumbWide.jpg", "legacy": {"wideheight": "126", "wide": "images/2014/03/10/business/dbpix-glaxo2/dbpix-glaxo2-thumbWide.jpg", "widewidth": "190"}, "subtype": "wide", "width": 190, "type": "image"}, {"height": 401, "url": "images/2014/03/10/business/dbpix-glaxo2/dbpix-glaxo2-articleLarge.jpg", "legacy": {"xlarge": "images/2014/03/10/business/dbpix-glaxo2/dbpix-glaxo2-articleLarge.jpg", "xlargewidth": "600", "xlargeheight": "401"}, "subtype": "xlarge", "width": 600, "type": "image"}, {"height": 75, "url": "images/2014/03/10/business/dbpix-glaxo2/dbpix-glaxo2-thumbStandard.jpg", "legacy": {"thumbnail": "images/2014/03/10/business/dbpix-glaxo2/dbpix-glaxo2-thumbStandard.jpg", "thumbnailwidth": "75", "thumbnailheight": "75"}, "subtype": "thumbnail", "width": 75, "type": "image"}], "pub_date": "2014-03-10T06:20:31Z", "source": "The New York Times", "news_desk": "Business", "keywords": [{"name": "glocations", "value": "India", "rank": "2"}, {"name": "glocations", "value": "Great Britain", "rank": "1"}, {"name": "organizations", "value": "GlaxoSmithKline PLC", "rank": "1"}, {"name": "subject", "value": "Stocks and Bonds", "rank": "3"}, {"name": "subject", "value": "Mergers, Acquisitions and Divestitures", "rank": "2"}, {"name": "subject", "value": "Drugs (Pharmaceuticals)", "rank": "1"}], "blog": [], "subsection_name": "Dealbook", "type_of_material": "Blog"}